Macular degeneration is a leading cause of visual impairment in those over 65 and can lead to blindness. One in three people will eventually suffer some degree of macular degeneration, which is caused by abnormal blood vessels under the retina, the light- sensitive part of the eye.

Yale Medicine ophthalmologists treat both the more common “dry” as well as the more dangerous “wet” form of the macular degeneration. While there is currently no cure for this disease, we offer the latest treatments to reduce the risk of vision loss and blindness. These include anti-VEGF drugs to attack proteins that create the abnormal blood vessels that cause macular degeneration and photodynamic therapy, in which patients ingest medication that is then activated with a laser.

In addition to treating patients, Yale Medicine macular degeneration specialists are among the world’s leading researchers of the disease. Patients receive not only top-flight care, but also benefit from the latest advances in treatment.